Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kristi Martin

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
JAMA|June 24, 2026
CMS' GLP-1 Bridge Demonstration-Questions and Potential ConsequencesRachel E Sachs, Kristi Martin
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|July 3, 2025
Referencing Drug Prices of Other Countries May Not Sustainably Lower Prices in the United States: Lessons From EuropeJens Grueger, Kristi Martin, Sean D Sullivan
Issue Brief (Commonwealth Fund)|July 13, 2017
Getting to the Root of High Prescription Drug PricesHenry Waxman, Bill Corr, Kristi Martin, et al.
Issue Brief (Commonwealth Fund)|July 12, 2018
What Commissioner Gottlieb's FDA Is Doing to Lower Prescription Drug Prices and Steps Congress Can Take to HelpHenry Waxman, Bill Corr, Kristi Martin, et al.
Journal of Managed Care & Specialty Pharmacy|September 12, 2025
Selected drugs, therapeutic alternatives, and price benchmarks for IPAY 2027 Medicare drug price negotiationSean D Sullivan, Emma M Cousin, Kevin H Li, et al.
Journal of Managed Care & Specialty Pharmacy|November 14, 2025
Drugs anticipated to be selected for Medicare price negotiation in 2026 for implementation in 2028Emma M Cousin, Kristi Martin, Ryan N Hansen, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 30, 2026
Spending Impact of the First Ten Drugs Selected for Medicare Drug Price Negotiation in the USYunjoo K Jeon, Ryan N Hansen, Nico Gabriel, et al.
Journal of Managed Care & Specialty Pharmacy|April 27, 2026
Assessment of IPAY 2027 Medicare drug price negotiation maximum fair prices with prices in most-favored nation reference countriesNico Gabriel, Kristi Martin, Emma M Cousin, et al.
Journal of Virology|October 29, 2003
Low frequency of cytotoxic T lymphocytes against the novel HLA-A*0201-restricted JC virus epitope VP1(p36) in patients with proven or possible progressive multifocal leukoencephalopathyRenaud A Du Pasquier, Marcelo J Kuroda, Joern E Schmitz, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
JAMA|June 24, 2026
CMS' GLP-1 Bridge Demonstration-Questions and Potential ConsequencesRachel E Sachs, Kristi Martin
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|July 3, 2025
Referencing Drug Prices of Other Countries May Not Sustainably Lower Prices in the United States: Lessons From EuropeJens Grueger, Kristi Martin, Sean D Sullivan
Issue Brief (Commonwealth Fund)|July 13, 2017
Getting to the Root of High Prescription Drug PricesHenry Waxman, Bill Corr, Kristi Martin, et al.
Issue Brief (Commonwealth Fund)|July 12, 2018
What Commissioner Gottlieb's FDA Is Doing to Lower Prescription Drug Prices and Steps Congress Can Take to HelpHenry Waxman, Bill Corr, Kristi Martin, et al.
Journal of Managed Care & Specialty Pharmacy|September 12, 2025
Selected drugs, therapeutic alternatives, and price benchmarks for IPAY 2027 Medicare drug price negotiationSean D Sullivan, Emma M Cousin, Kevin H Li, et al.
Journal of Managed Care & Specialty Pharmacy|November 14, 2025
Drugs anticipated to be selected for Medicare price negotiation in 2026 for implementation in 2028Emma M Cousin, Kristi Martin, Ryan N Hansen, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 30, 2026
Spending Impact of the First Ten Drugs Selected for Medicare Drug Price Negotiation in the USYunjoo K Jeon, Ryan N Hansen, Nico Gabriel, et al.
Journal of Managed Care & Specialty Pharmacy|April 27, 2026
Assessment of IPAY 2027 Medicare drug price negotiation maximum fair prices with prices in most-favored nation reference countriesNico Gabriel, Kristi Martin, Emma M Cousin, et al.
Journal of Virology|October 29, 2003
Low frequency of cytotoxic T lymphocytes against the novel HLA-A*0201-restricted JC virus epitope VP1(p36) in patients with proven or possible progressive multifocal leukoencephalopathyRenaud A Du Pasquier, Marcelo J Kuroda, Joern E Schmitz, et al.
Pageof 1